To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too
MMWFortschrittederMedizin 147(33-34): 51
2005
ISSN/ISBN: 1438-3276 PMID: 16138641 Document Number: 586057
Document emailed within 1 workday
Related Documents
Halim, E.F.A.E.; Reda, A.A.; Hendi, A.A.K.; Zaki, S.A.; Essa, E.S.; Khalifa, A.S. 2012: Apolipoprotein e gene variants as a risk factor for coronary artery disease in type 2 diabetic Egyptian patients Egyptian Journal of Immunology 19(1): 1-10El-Diasty, A.M.; Shahin, M. 2008: Anticardiolipin antibodies in diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy Egyptian Journal of Immunology 15(1): 101-107
Yokota, C. 2003: Prevention of cardiovascular disease in type 2 diabetic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 61(7): 1161-1166
Shestakova, M.V.; Koshel', L.V.; Vagodin, V.A.; Dedov, I.I. 2006: Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis Terapevticheskii Arkhiv 78(5): 60-64
Mehta, R.H.; Sketch, M.H. 2004: Percutaneous coronary revascularization in diabetic patients with multivessel coronary artery disease: importance and feasibility Journal of Invasive Cardiology 16(3): 107-108
Chmielecki, K.; Mroszczyk, M.; Loba, J.; Torzecka, W.; Chromińska, D.; Szosland, K. 1982: Cardiovascular disease mortality among diabetic patients in the city of Lodz Wiadomosci Lekarskie 35(18): 1113-1117
Henry, P. 2008: Coronary artery disease in diabetic patients La Revue du Praticien 58(14): 1561-1564
Eckert, S.; Tschöpe, D. 2005: Cardiovascular protection in diabetic patients with heart disease in the doctor's office MMW Fortschritte der Medizin 147(43): 43-46
Mwita, J.C.; Mugusi, F.; Lwakatare, J.; Chiwanga, F. 2012: Hypertension control and other cardiovascular risk factors among diabetic patients at Muhimbili National Hospital, Tanzania East African Journal of Public Health 9(2): 70-73
Wagner, M.; Goetghebeur, M.; Merikle, E.; Pandya, A.; Chu, P.; Taylor, D.C.A. 2009: Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada Canadian Journal of Clinical Pharmacology 16(2): E331-E345
Balasubramanian, R.; Varadharajan, S.; Kathale, A.; Nagraj, L.M.; Periyandavar, I.; Nayak, U.P.; Sharma, A.; Bolmall, C.; Baliga, V.P. 2008: Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients Journal of the Indian Medical Association 106(7): 464-467
Fujii, J. 1997: Coronary artery disease, heart failure and cardiomyopathy in diabetic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 765-771
Scheen, A.J.; Paquot, N. 2013: Use of metformin in diabetic patients with cardiac disease: benefit-risk balance Revue Medicale Suisse 9(395): 1527-1533
Joshi, M.D.; Amayo, E.O. 2006: Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi East African Medical Journal 83(7): 405-6; author reply 406-7
Joshi, M.D.; Amayo, E.O. 2006: Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi East African Medical Journal 83(7): 405-6; author reply 406-7
Pola, P.; Kumar, R.; Reddy, A.P.; Rajagopal, G.; Harinarayan, C.V.; Suresh, V.; Suchitra, M.M.; Sachan, A. 2009: Efficacy of low dose atorvastatin in diabetic dyslipidaemia Journal of the Indian Medical Association 107(11): 807-809
Baumann, H.; Meyer, P.; Winter, K.; Lorenz, G. 1985: Sialochemical and morphology studies of the submandibular gland of the diabetic patient--a contribution to diabetic sialadenosis Laryngologie Rhinologie Otologie 64(10): 542-546
Casoinic, F.; Sâmpelean, D.; Bădău, C.ăt.ăl.; Prună, L. 2009: Nonalcoholic fatty liver disease--a risk factor for microalbuminuria in type 2 diabetic patients Romanian Journal of Internal Medicine 47(1): 55-59
Zhang, Q.; Fang, Y.-h.; Zhang, R.-y.; Hu, J.; Yang, Z.-k.; Ni, J.; Zhang, J.-s.; Shen, W.-f. 2006: Drug-eluting stents improve clinical outcomes in Chinese diabetic patients with de novo coronary artery disease Chinese Medical Journal 119(18): 1576-1579
Benson, W.H.; Farber, M.E. 1989: Diabetic retinopathy in a rural diabetic population. Prevalence and risk West Virginia Medical Journal 85(4): 141-143